ZA895573B - Bordetella pertussis vaccine - Google Patents

Bordetella pertussis vaccine

Info

Publication number
ZA895573B
ZA895573B ZA895573A ZA895573A ZA895573B ZA 895573 B ZA895573 B ZA 895573B ZA 895573 A ZA895573 A ZA 895573A ZA 895573 A ZA895573 A ZA 895573A ZA 895573 B ZA895573 B ZA 895573B
Authority
ZA
South Africa
Prior art keywords
bordetella pertussis
pertussis vaccine
vaccine
bordetella
pertussis
Prior art date
Application number
ZA895573A
Other languages
English (en)
Inventor
Carine Capiau
Capiau Carine
Camille Locht
Locht Camille
Original Assignee
Smithkline Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Biolog filed Critical Smithkline Biolog
Publication of ZA895573B publication Critical patent/ZA895573B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA895573A 1988-07-22 1989-07-21 Bordetella pertussis vaccine ZA895573B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22299188A 1988-07-22 1988-07-22

Publications (1)

Publication Number Publication Date
ZA895573B true ZA895573B (en) 1990-07-25

Family

ID=22834543

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895573A ZA895573B (en) 1988-07-22 1989-07-21 Bordetella pertussis vaccine

Country Status (17)

Country Link
EP (1) EP0352250B1 (xx)
JP (1) JP2798986B2 (xx)
KR (1) KR900001852A (xx)
AP (1) AP8900132A0 (xx)
AT (1) ATE142697T1 (xx)
AU (1) AU3827089A (xx)
DE (1) DE68927144T2 (xx)
DK (1) DK355789A (xx)
FI (1) FI893512A (xx)
HK (1) HK1004568A1 (xx)
HU (1) HUT52701A (xx)
IL (1) IL90994A0 (xx)
NO (1) NO892997L (xx)
NZ (1) NZ229954A (xx)
OA (1) OA10038A (xx)
PT (1) PT91248A (xx)
ZA (1) ZA895573B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296765B1 (en) * 1987-06-24 1994-06-08 Teijin Limited Bordetella pertussis variants
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
EP0396964B1 (en) * 1989-04-28 1995-09-06 SCLAVO S.p.A. Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
ATE143692T1 (de) * 1989-11-29 1996-10-15 Smithkline Beecham Biolog Neuer impfstoff
IT1248735B (it) * 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
DE69434000T3 (de) * 1993-10-05 2008-11-06 UCB Pharma Ltd., Slough Impfstoffzusammensetzungen
US20030072774A1 (en) * 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
EP0396964B1 (en) * 1989-04-28 1995-09-06 SCLAVO S.p.A. Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines

Also Published As

Publication number Publication date
PT91248A (pt) 1990-02-08
AU3827089A (en) 1990-01-25
DK355789A (da) 1990-01-23
HK1004568A1 (en) 1998-11-27
AP8900132A0 (en) 1991-01-14
DE68927144D1 (de) 1996-10-17
EP0352250A2 (en) 1990-01-24
NZ229954A (en) 1992-09-25
NO892997L (no) 1990-01-23
IL90994A0 (en) 1990-02-09
JPH0284183A (ja) 1990-03-26
JP2798986B2 (ja) 1998-09-17
NO892997D0 (no) 1989-07-21
FI893512A0 (fi) 1989-07-20
EP0352250A3 (en) 1990-11-14
DE68927144T2 (de) 1997-03-20
DK355789D0 (da) 1989-07-18
KR900001852A (ko) 1990-02-27
ATE142697T1 (de) 1996-09-15
EP0352250B1 (en) 1996-09-11
HUT52701A (en) 1990-08-28
FI893512A (fi) 1990-01-23
OA10038A (en) 1996-10-14

Similar Documents

Publication Publication Date Title
GB8924438D0 (en) Vaccine composition
EP0484621A3 (en) Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
EP0391997A4 (en) Vaccine
EP0454735A4 (en) Vaccine composition
EP0474646A4 (en) Bordetella vaccines
GB8805233D0 (en) Vaccine against pasteurella
IL90994A0 (en) Bordetella pertussis vaccine
EP0427768A4 (en) Polypeptide pertussis toxin vaccine
GB9017370D0 (en) Tuberculosis vaccine
GB8918689D0 (en) 25/15 vaccine
GR3019065T3 (en) Vaccine Composition
GB8704647D0 (en) Vaccine
IE892369L (en) Bordetella pertussis vaccine
OA09636A (en) Vaccine
GB2091551B (en) Vaccine against pertussis
EP0453452A4 (en) Vaccine
IE882054L (en) Vaccine
GB8805603D0 (en) Vaccine
IL84276A0 (en) Vaccine against whooping cough
GB8804688D0 (en) Vaccines
IE880831L (en) Vaccines
GB8810807D0 (en) Vaccines
IE882702L (en) Antimalaria vaccines
GB8922651D0 (en) Vaccine
ZA909516B (en) Novel vaccine